NGL Fine Chem Intrinsic Value
NGLFINE • Healthcare
Current Stock Price
₹2211.70
Primary Intrinsic Value
₹1371.04
Market Cap
₹663.5 Cr
-38.0%
Downside
Median Value
₹1371.04
Value Range
₹664 - ₹3253
Assessment
Trading Above Calculated Value
Safety Margin
-61.3%
NGLFINE Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1371.04 | ₹1096.83 - ₹1645.25 | -38.0% | EPS: ₹62.32, Sector P/E: 22x |
| Book Value Method | asset | ₹1880.00 | ₹1692.00 - ₹2068.00 | -15.0% | Book Value/Share: ₹940.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹3253.33 | ₹2928.00 - ₹3578.66 | +47.1% | Revenue/Share: ₹1626.67, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹2533.33 | ₹2280.00 - ₹2786.66 | +14.5% | EBITDA: ₹76.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹1225.47 | ₹980.38 - ₹1470.56 | -44.6% | CF Growth: 7.5%, Discount: 15% |
| PEG Ratio Method | growth | ₹663.51 | ₹597.16 - ₹729.86 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹962.84 | ₹866.56 - ₹1059.12 | -56.5% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹1600.00 | ₹1440.00 - ₹1760.00 | -27.7% | ROE: 14.2%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹1148.07 | ₹1033.26 - ₹1262.88 | -48.1% | EPS: ₹62.32, BVPS: ₹940.00 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
NGLFINE Intrinsic Value Analysis
What is the intrinsic value of NGLFINE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of NGL Fine Chem (NGLFINE) is ₹1371.04 (median value). With the current market price of ₹2211.70, this represents a -38.0% variance from our estimated fair value.
The valuation range spans from ₹663.51 to ₹3253.33, indicating ₹663.51 - ₹3253.33.
Is NGLFINE undervalued or overvalued?
Based on our multi-method analysis, NGL Fine Chem (NGLFINE) appears to be trading above calculated value by approximately 38.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.34 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 14.2% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.13x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for NGL Fine Chem
Additional stock information and data for NGLFINE
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹36 Cr | ₹19 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹21 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹35 Cr | ₹22 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹14 Cr | ₹7 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹27 Cr | ₹15 Cr | Positive Free Cash Flow | 8/10 |